ReviewBMC global and public health2026
Reducing healthcare emissions in the United States in the era of federal environmental deregulation: established and emerging mitigation opportunities and concomitant benefits.
Review in BMC global and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The United States (US) healthcare sector leads the world in per capita greenhouse gas emissions, contributing disproportionately to global climate change. The recent reversal of federal climate regulations has increased the need for voluntary and urgent action from the US healthcare sector. In 2022, the US healthcare sector emissions resulted in over 425,000 disability-adjusted life years lost, reflecting the direct human cost of healthcare-related greenhouse gas emissions. Climate change worsens health outcomes and disrupts access to care - these impacts fall heavily on vulnerable populations including low-income communities, indigenous populations, the elderly, and children. Three key areas for decarbonization include infrastructure, supply chains, and operations and can be accounted for and addressed through the Greenhouse Gas Protocol framework. Some established mitigation strategies include transitioning to renewable energy, reducing medical waste, adopting lower emissions anesthetics and inhalers, and implementing sustainable food management. However, current greenhouse gas inventories utilized by health systems may not yet account for the rapidly expanding landscape of technology in healthcare and its growing contribution to emissions. Emerging priorities for mitigation that are often overlooked include reducing emissions associated with medical conferences and the growing energy demands of artificial intelligence. Here, we discuss how decarbonization not only reduces emissions but also provides important co-benefits, including better air quality, climate resilience, reduced costs, and improved workforce well-being.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.